FDA Alerts
-
FDA Approves Humanized Monoclonal Antibody For Migraine Treatment.
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Emgality™ (galcanezumab-gnlm) 120 mg injection for the preventive ... -
FDA approved a new drug for seizures associated with Dravet Syndrome
Recently FDA has approved DIACOMIT(stiripentol) for seizures associated with dravet syndrome in patients. Dravet syndrome is a rare genetic condition that usually appears during ... -
FDA approves a new drug to treat malaria which could help millions.
The Food and Drug Administration has approved the drug Krintafel (tafenoquine) for the treatment of malaria following a Priority Review this past Friday. The ... -
FDA recalls a anti hypertensive drug due to cancer concerns
Hypertension is on of the common condition seen in 6 out of 10 members in the world, Generally physician do advice various kind of ... -
FDA approves a new clinical trial for non-healing wounds.
FDA has approved clinical trials in Samford health for its institution second ever adipose-derived stem cell clinical trial which is designed to treat non-healing ...
